IL159496A0 - Chemically-modified progenipoietin conjugates - Google Patents
Chemically-modified progenipoietin conjugatesInfo
- Publication number
- IL159496A0 IL159496A0 IL15949602A IL15949602A IL159496A0 IL 159496 A0 IL159496 A0 IL 159496A0 IL 15949602 A IL15949602 A IL 15949602A IL 15949602 A IL15949602 A IL 15949602A IL 159496 A0 IL159496 A0 IL 159496A0
- Authority
- IL
- Israel
- Prior art keywords
- progenipoietin
- conjugates
- chemically
- modified
- progenipoietin conjugates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30036201P | 2001-06-22 | 2001-06-22 | |
PCT/US2002/018810 WO2003000179A2 (en) | 2001-06-22 | 2002-06-14 | Chemically-modified progenipoietin conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159496A0 true IL159496A0 (en) | 2004-06-01 |
Family
ID=23158770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15949602A IL159496A0 (en) | 2001-06-22 | 2002-06-14 | Chemically-modified progenipoietin conjugates |
Country Status (15)
Country | Link |
---|---|
US (1) | US20060052291A1 (xx) |
EP (1) | EP1404354A4 (xx) |
JP (1) | JP2005512951A (xx) |
KR (1) | KR20040069980A (xx) |
CN (1) | CN101426511A (xx) |
BR (1) | BR0211192A (xx) |
CA (1) | CA2450950A1 (xx) |
CZ (1) | CZ20033537A3 (xx) |
EA (1) | EA006368B1 (xx) |
IL (1) | IL159496A0 (xx) |
MX (1) | MXPA04000068A (xx) |
NO (1) | NO20035742L (xx) |
PL (1) | PL367410A1 (xx) |
WO (1) | WO2003000179A2 (xx) |
ZA (1) | ZA200309863B (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008530163A (ja) * | 2005-02-16 | 2008-08-07 | マイクロメット アクツィエン ゲゼルシャフト | タンパク質およびポリペプチド多量体の分離のための活性化型ポリマーの使用 |
EP1861125A2 (en) * | 2005-03-23 | 2007-12-05 | Nektar Therapeutics Al, Corporation | Conjugates of an hgh moiety and peg derivatives |
WO2010123827A1 (en) * | 2009-04-20 | 2010-10-28 | The Regents Of The University Of California | Engineered demeter 5-methylcytosine dna glycosylase with improved yield, stability and solubility |
KR200483859Y1 (ko) | 2015-10-28 | 2017-07-04 | 주식회사 키유틸리티 | 충전장치 수납 및 휴대용 기기 거치용 장치 |
KR102619071B1 (ko) * | 2017-10-11 | 2023-12-27 | 엘랑코 유에스 인코포레이티드 | 돼지 g-csf 변이체 및 그 용도 |
EP3731871B1 (en) * | 2017-12-29 | 2023-10-04 | F. Hoffmann-La Roche AG | Process for providing pegylated protein composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0702723T3 (da) * | 1993-04-21 | 2003-01-13 | Pasteur Institut | Biokompatibelt implantat til ekspression og udskillelse af terapeutisk forbindelse in vivo |
US5730990A (en) * | 1994-06-24 | 1998-03-24 | Enzon, Inc. | Non-antigenic amine derived polymers and polymer conjugates |
GB2294047A (en) * | 1994-10-14 | 1996-04-17 | Merck & Co Inc | Synthetic peptides for use as epitopes specific for HIV |
SE507527C2 (sv) * | 1996-10-11 | 1998-06-15 | Ericsson Telefon Ab L M | Flerbandsmottagare som genererar en mellanfrekvens som är gemensam för de olika frekvensbanden, och förfarande för densamma |
US6251665B1 (en) * | 1997-02-07 | 2001-06-26 | Cem Cezayirli | Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom |
-
2002
- 2002-06-14 IL IL15949602A patent/IL159496A0/xx unknown
- 2002-06-14 PL PL02367410A patent/PL367410A1/xx unknown
- 2002-06-14 CZ CZ20033537A patent/CZ20033537A3/cs unknown
- 2002-06-14 KR KR10-2003-7016759A patent/KR20040069980A/ko not_active Application Discontinuation
- 2002-06-14 EA EA200400070A patent/EA006368B1/ru not_active IP Right Cessation
- 2002-06-14 WO PCT/US2002/018810 patent/WO2003000179A2/en not_active Application Discontinuation
- 2002-06-14 EP EP02742060A patent/EP1404354A4/en not_active Withdrawn
- 2002-06-14 US US10/481,935 patent/US20060052291A1/en not_active Abandoned
- 2002-06-14 CA CA002450950A patent/CA2450950A1/en not_active Abandoned
- 2002-06-14 MX MXPA04000068A patent/MXPA04000068A/es unknown
- 2002-06-14 CN CNA028165179A patent/CN101426511A/zh active Pending
- 2002-06-14 JP JP2003506625A patent/JP2005512951A/ja not_active Abandoned
- 2002-06-14 BR BR0211192-6A patent/BR0211192A/pt not_active Withdrawn
-
2003
- 2003-12-19 ZA ZA200309863A patent/ZA200309863B/en unknown
- 2003-12-19 NO NO20035742A patent/NO20035742L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101426511A (zh) | 2009-05-06 |
CA2450950A1 (en) | 2003-01-03 |
PL367410A1 (en) | 2005-02-21 |
NO20035742L (no) | 2004-02-23 |
ZA200309863B (xx) | 2006-06-28 |
EA200400070A1 (ru) | 2004-06-24 |
WO2003000179A2 (en) | 2003-01-03 |
NO20035742D0 (no) | 2003-12-19 |
CZ20033537A3 (cs) | 2004-08-18 |
KR20040069980A (ko) | 2004-08-06 |
WO2003000179A3 (en) | 2003-12-11 |
US20060052291A1 (en) | 2006-03-09 |
JP2005512951A (ja) | 2005-05-12 |
EP1404354A2 (en) | 2004-04-07 |
EA006368B1 (ru) | 2005-12-29 |
EP1404354A4 (en) | 2005-04-20 |
BR0211192A (pt) | 2004-10-26 |
MXPA04000068A (es) | 2005-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400466A3 (en) | G-csf conjugates | |
AU2002351746A8 (en) | Erythropoietin conjugates | |
GB0119665D0 (en) | Conjugates | |
EP1385556A4 (en) | PEPTIDE CONJUGATES WITH AFFINITY FOR GASTRIN RECEPTORS | |
EP1379689A4 (en) | OLIGONUCLEOTIDE CONJUGATES | |
IL159496A0 (en) | Chemically-modified progenipoietin conjugates | |
AU2001289307A1 (en) | Chemically-modified myelopoietin conjugates | |
GB0116529D0 (en) | Multi scriber | |
GB2382347B (en) | Hemoglobin conjugates | |
AU2003292197A8 (en) | Lna-cpg conjugates | |
GB0101328D0 (en) | Cartons | |
GB0109684D0 (en) | Earpiece | |
DE60236449D1 (en) | Neue alpha-oxidierte carbonsäure-phenethylamid-derivate | |
GB2371537B (en) | Cartons | |
EP1401482A4 (en) | YIN YANG-1 | |
TW468538U (en) | Improved socket | |
AU7426601A (en) | Gene-regulating conjugates | |
GB0111831D0 (en) | Former | |
AU2002256425A1 (en) | Gastrin-receptor-avid peptide conjugates | |
GB2372030B (en) | Cartons | |
GB0125208D0 (en) | Delivery form | |
HU0101742D0 (en) | Deflector | |
TW487103U (en) | Fast assembly carton | |
AU145461S (en) | Side form bracket | |
AU145462S (en) | Side form bracket |